Study of Blinatumomab in Japanese Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Clinical trial NCT02412306 · COMPLETED
Trial details
- NCT number
- NCT02412306
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-04
- Primary completion
- 2019-02-06
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.